| Financial Year |
March 31 2023 |
| Monetary Funds |
127,739,904.48 |
| Held-for-trading Financial Assets |
540,950.00 |
| Notes Receivable |
1,629,364.00 |
| Accounts Receivable |
400,758,594.21 |
| Advances to Suppliers |
22,212,376.14 |
| Other Receivables |
21,471,064.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
240,356,268.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,287,603.35 |
| Total Current Assets |
833,791,185.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
38,359,978.71 |
| Investment Properties |
9,340,216.70 |
| Fixed Assetes |
779,002,551.81 |
| Under-construction Projects |
1,452,474,550.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
182,284,529.27 |
| R&D expenses |
-- |
| Goodwill |
447,528.95 |
| Long-Term Deferred and Prepaid Expenses |
140,880.49 |
| Deferred Income Tax Assets |
9,333,729.35 |
| Other Non-Current Assets |
5,421,247.37 |
| Sub-Total of Non-Current Assets |
2,488,359,542.42 |
| Total Assets |
3,322,150,728.02 |
| Short-Term Loans |
221,041,063.72 |
| Trading Financial liabilities |
1,625,470.00 |
| Notes Payable |
96,622,913.80 |
| Accounts Payable |
411,213,000.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
52,382,556.28 |
| Taxes Payable |
26,852,939.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
27,532,086.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,820,047.14 |
| Other Current Liabilities |
2,280,720.35 |
| Sub-Total of Current Liabilities |
879,151,153.73 |
| Long-term Loans |
435,150,435.29 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
486,805,505.94 |
| Total Liabilities |
1,365,956,659.67 |
| Paid-In Capital(Or Share Stock) |
342,434,040.00 |
| Capital Surplus |
132,896,178.31 |
| Surplus Reserve |
136,359,036.26 |
| LESS:Treasury Stock |
16,346,400.00 |
| Undistributed Profits |
1,355,296,395.90 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,956,194,068.35 |
| Owner's Equity（Stockholder's Equity） |
1,956,194,068.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,322,150,728.02 |
